Literature DB >> 24747421

Noninvasive identification of epicardial ventricular tachycardia substrate by magnetic resonance-based signal intensity mapping.

Angel Arenal1, Esther Pérez-David2, Pablo Avila2, Javier Fernández-Portales3, Verónica Crisóstomo3, Claudia Báez3, Javier Jiménez-Candil3, José L Rubio-Guivernau4, María J Ledesma-Carbayo4, Gerard Loughlin2, Javier Bermejo2, Francisco M Sánchez-Margallo3, Francisco Fernández-Avilés2.   

Abstract

BACKGROUND: Endo-epicardial substrate ablation reduces ventricular tachycardia (VT) recurrences; however, not all patients in whom the epicardium is explored have a VT substrate. Contrast-enhanced magnetic resonance imaging (ceMRI) is used to characterize VT substrate after myocardial infarction.
OBJECTIVE: The purpose of this study was to determine if epicardial VT substrate can be identified noninvasively by ceMRI-based endo-epicardial signal intensity (SI) mapping.
METHODS: Myocardial infarction was induced in 31 pigs. Four or 16 weeks later, ceMRI was obtained, and the averaged subendocardial and subepicardial SIs were projected onto 3-dimensional endocardial and epicardial shells in which dense scar, heterogeneous tissue (HT), and normal tissue were differentiated. An HT channel was defined as a corridor of HT surrounded by dense scar and connected to normal tissue. A "patchy" scar pattern was defined as the presence of at least 3 dense scar islets surrounded by HT forming ≥2 HT channels. Electrophysiologic study was performed after ceMRI.
RESULTS: Thirty-three different sustained monomorphic VTs (291 ± 49 ms) were induced in 25 pigs. Mid-diastolic electrograms were recorded in the endocardium (endocardial VT) in 17 and in the epicardium (epicardial VT) in 13. Epicardial SI mapping showed that scar area was similar in animals with and without epicardial VT (24 ± 6 cm2 vs. 25 ± 12 cm2), but HT covered a higher surface of the epicardial scar in animals with VT (76 ± 6% vs. 61 ± 10%, P = .03). A patchy scar pattern was observed in all animals with epicardial VT but only in 3 animals without VT (P < .001).
CONCLUSION: CeMRI-based SI mapping allows identification of the epicardial VT substrate.
Copyright © 2014 Heart Rhythm Society. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Arrhythmogenic substrate; Epicardium; Magnetic resonance imaging; Ventricular tachycardia

Mesh:

Year:  2014        PMID: 24747421     DOI: 10.1016/j.hrthm.2014.04.022

Source DB:  PubMed          Journal:  Heart Rhythm        ISSN: 1547-5271            Impact factor:   6.343


  10 in total

1.  A feasibility study of arrhythmia risk prediction in patients with myocardial infarction and preserved ejection fraction.

Authors:  Dongdong Deng; Hermenegild J Arevalo; Adityo Prakosa; David J Callans; Natalia A Trayanova
Journal:  Europace       Date:  2016-12       Impact factor: 5.214

2.  Common swine models of cardiovascular disease for research and training.

Authors:  Verónica Crisóstomo; Fei Sun; Manuel Maynar; Claudia Báez-Díaz; Virginia Blanco; Monica Garcia-Lindo; Jesús Usón-Gargallo; Francisco Miguel Sánchez-Margallo
Journal:  Lab Anim (NY)       Date:  2016-02       Impact factor: 12.625

Review 3.  Cardiac Magnetic Resonance for Ventricular Arrhythmia Therapies in Patients with Coronary Artery Disease.

Authors:  Kivanc Yalin; Ebru Golcuk; Tolga Aksu
Journal:  J Atr Fibrillation       Date:  2015-06-30

4.  Hybrid Ablation of Ventricular Tachycardia: a Single-Centre Experience.

Authors:  Mindy Vroomen; Bart Maesen; Mark La Meir; Justin G L Luermans; Kevin Vernooy; Jos G Maessen; Harry J Crijns; Laurent Pison
Journal:  J Atr Fibrillation       Date:  2019-02-28

5.  Epicardial electroanatomical mapping, radiofrequency ablation, and lesion imaging in the porcine left ventricle under real-time magnetic resonance imaging guidance-an in vivo feasibility study.

Authors:  Rahul K Mukherjee; Sébastien Roujol; Henry Chubb; James Harrison; Steven Williams; John Whitaker; Louisa O'Neill; John Silberbauer; Radhouene Neji; Rainer Schneider; Thomas Pohl; Tom Lloyd; Mark O'Neill; Reza Razavi
Journal:  Europace       Date:  2018-09-01       Impact factor: 5.214

6.  Prognostic value role of radiofrequency lesion size by cardiac magnetic resonance imaging on outcomes of ablation in patients with ischemic scar-related ventricular tachycardia: A single center pilot study.

Authors:  Tümer Erdem Guler; Kivanç Yalin; Tolga Aksu; Ebru Golcuk; Sukru Sanli; Ahmet Kaya Bilge; Kamil Adalet
Journal:  Medicine (Baltimore)       Date:  2018-11       Impact factor: 1.817

Review 7.  Recent advances in the management of ventricular tachyarrhythmias.

Authors:  Syeda Atiqa Batul; Brian Olshansky; John D Fisher; Rakesh Gopinathannair
Journal:  F1000Res       Date:  2017-06-29

8.  Evaluation of the use of unipolar voltage amplitudes for detection of myocardial scar assessed by cardiac magnetic resonance imaging in heart failure patients.

Authors:  Uyên Châu Nguyên; Francesco Maffessanti; Masih Mafi-Rad; Giulio Conte; Stef Zeemering; François Regoli; Maria Luce Caputo; Antonius M W van Stipdonk; Sebastiaan C A M Bekkers; Daniel Suerder; Tiziano Moccetti; Rolf Krause; Frits W Prinzen; Kevin Vernooy; Angelo Auricchio
Journal:  PLoS One       Date:  2017-07-05       Impact factor: 3.240

Review 9.  Novel approaches for the treatment of ventricular tachycardia.

Authors:  Michael Spartalis; Eleftherios Spartalis; Eleni Tzatzaki; Diamantis I Tsilimigras; Demetrios Moris; Christos Kontogiannis; Efthimios Livanis; Dimitrios C Iliopoulos; Vassilis Voudris; George N Theodorakis
Journal:  World J Cardiol       Date:  2018-07-26

10.  Time-efficient three-dimensional transmural scar assessment provides relevant substrate characterization for ventricular tachycardia features and long-term recurrences in ischemic cardiomyopathy.

Authors:  Susana Merino-Caviedes; Lilian K Gutierrez; José Manuel Alfonso-Almazán; Santiago Sanz-Estébanez; Lucilio Cordero-Grande; Jorge G Quintanilla; Javier Sánchez-González; Manuel Marina-Breysse; Carlos Galán-Arriola; Daniel Enríquez-Vázquez; Carlos Torres; Gonzalo Pizarro; Borja Ibáñez; Rafael Peinado; Jose Luis Merino; Julián Pérez-Villacastín; José Jalife; Mariña López-Yunta; Mariano Vázquez; Jazmín Aguado-Sierra; Juan José González-Ferrer; Nicasio Pérez-Castellano; Marcos Martín-Fernández; Carlos Alberola-López; David Filgueiras-Rama
Journal:  Sci Rep       Date:  2021-09-28       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.